12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Friday's intraday session, several healthcare stocks experienced significant movements. Baudax Bio, CymaBay Therapeutics, Renalytix, Cyteir Therapeutics, Enochian BioSciences, and Gracell Biotechnologies saw increases, with Baudax Bio leading with a 130.7% increase. On the other hand, Apyx Medical, Surgalign Holdings, Unicycive Therapeutics, PetVivo Hldgs, CalciMedica, and Genfit experienced declines, with Apyx Medical leading the losses with a 27.5% decrease.
June 30, 2023 | 5:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Baudax Bio shares increased by 130.7% to $1.2 during Friday's regular session.
The significant increase in Baudax Bio's share price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
CymaBay Therapeutics stock increased by 41.61% to $11.1.
The significant increase in CymaBay Therapeutics' stock price is likely to have a positive impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Apyx Medical shares declined by 27.5% to $4.86 during Friday's regular session.
The significant decrease in Apyx Medical's share price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
CalciMedica stock declined by 15.25% to $4.11.
The significant decrease in CalciMedica's stock price is likely to have a negative impact on its stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100